Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Prednisolone
United Therapeutics Europe Ltd
COPD Exacerbation
1 trial -
Prevenar 13
United Therapeutics Europe Ltd
Sepsis
1 trial -
Prilocaine (Hyperbaric 2%)
United Therapeutics Europe Ltd
Cervical Incompetence in Pregnancy as Antepartum Condition
1 trial -
Recombinant FSH (follitropin alpha)
United Therapeutics Europe Ltd
Ovulation Induction
1 trial -
Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)
United Therapeutics Europe Ltd
Diarrhea
1 trial -
Remodulin
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
Rifaximin
United Therapeutics Europe Ltd
Clostridium Difficile Infection
1 trial -
Rifaximin
United Therapeutics Europe Ltd
Nonalcoholic Fatty Liver Disease
1 trial -
SALBUTAMOL
United Therapeutics Europe Ltd
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
1 trial -
Semaglutide
United Therapeutics Europe Ltd
Obesity
1 trial -
Sertraline
United Therapeutics Europe Ltd
Generalised Anxiety Disorder
1 trial -
Sesame Oil
United Therapeutics Europe Ltd
Caloric Restriction
1 trial -
Sham (Comparator) Plasma Ball
United Therapeutics Europe Ltd
Phantom Limb Pain
1 trial -
Silver Sulfadiazine
United Therapeutics Europe Ltd
Superficial Partial Thickness Burn
1 trial -
Standard of care plus Epoprostenol infusion for 8 hours (hrs) per day up to 5 days maximum
United Therapeutics Europe Ltd
Frostbite
1 trial -
Subcutaneous Treprostinil
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
Sulfadoxine-pyrimethamine
United Therapeutics Europe Ltd
Malaria (Uncomplicated)
1 trial -
Tadalafil
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
Teriparatide
United Therapeutics Europe Ltd
Osteoporosis
1 trial -
Teriparatide
United Therapeutics Europe Ltd
Stress Fracture of Tibia or Fibula
1 trial -
Topiramate
United Therapeutics Europe Ltd
Alcohol Dependence
1 trial -
Topiramate
United Therapeutics Europe Ltd
PTSD
1 trial -
Topiramate
United Therapeutics Europe Ltd
Traumatic Brain Injury (TBI)
1 trial -
Tranexamic Acid 1000 mg/10ml normal saline infusion
United Therapeutics Europe Ltd
Postpartum Hemorrhage
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources